Madrigal Pharmaceuticals, Inc.
DE ˙ DB ˙ US5588681057
426,20 € ↑6,40 (1,52%)
2026-06-04
DEL PRIS
SecurityDE:YDO1 / Madrigal Pharmaceuticals, Inc.
InstitutionUs Bancorp \de\
Latest Disclosed Ownership835 shares
Latest Disclosed Value $ 437,097
Us Bancorp \de\ reports 89.34% increase in ownership of YDO1 / Madrigal Pharmaceuticals, Inc.

On May 14, 2026 - Us Bancorp \de\ filed a 13F-HR form disclosing ownership of 835 shares of Madrigal Pharmaceuticals, Inc. (DE:YDO1) valued at $376,000 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 30, 2026 disclosing 441 shares of Madrigal Pharmaceuticals, Inc.. This represents a change in shares of 89.34% during the quarter. The current value of the position is $355,877 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 835 394 89.34 437 70.70 0.0002
2026-01-30 2025-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 441 53 13.66 257 44.63 0.0003
2025-11-12 2025-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 388 1 0.26 178 51.28 0.0002
2025-07-24 2025-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 387 -127 -24.71 117 -31.18 0.0001
2025-05-08 2025-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 514 23 4.68 170 12.58 0.0002
2025-02-05 2024-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 491 -72 -12.79 152 26.89 0.0002
2024-10-28 2024-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 563 -229 -28.91 119 -46.15 0.0002
2024-08-07 2024-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 792 58 7.90 222 12.76 0.0003
2024-05-08 2024-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 734 -659 -47.31 196 -39.13 0.0003
2024-02-09 2023-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 1,393 -854 -38.01 322 -1.83 0.0005
2023-11-03 2023-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 2,247 -167 -6.92 328 -41.11 0.0005
2023-08-10 2023-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 2,414 493 25.66 558 19.78 0.0009
2023-05-09 2023-03-31 13F MADRIGAL PHARMACEUTICALS COMMON STOCK 558868105 1,921 1,421 284.20 465 220.69 0.0008
2023-02-13 2022-12-31 13F MADRIGAL PHARMACEUTICALS COMMON STOCK 558868105 500 142 39.66 145 530.43 0.0003
2022-10-27 2022-09-30 13F MADRIGAL PHARMACEUTICALS COMMON STOCK 558868105 358 202 129.49 23 109.09 0.0000
2022-08-01 2022-06-30 13F MADRIGAL PHARMACEUTICALS COMMON STOCK 558868105 156 -194 -55.43 11 -67.65 0.0000
2022-05-11 2022-03-31 13F MADRIGAL PHARMACEUTICALS COMMON STOCK 558868105 350 37 11.82 34 25.93 0.0001
2022-02-11 2021-12-31 13F MADRIGAL PHARMACEUTICALS COMMON STOCK 558868105 313 287 1,103.85 27 1,250.00 0.0000
2021-11-10 2021-09-30 13F MADRIGAL PHARMACEUTICALS COMMON STOCK 558868105 26 -79 -75.24 2 -80.00 0.0000
2021-08-05 2021-06-30 13F MADRIGAL PHARMACEUTICALS COMMON STOCK 558868105 105 -8 -7.08 10 -23.08 0.0000
2021-04-28 2021-03-31 13F MADRIGAL PHARMACEUTICALS COMMON STOCK 558868105 113 79 232.35 13 225.00 0.0000
2021-02-04 2020-12-31 13F MADRIGAL PHARMACEUTICALS COMMON STOCK 558868105 34 26 325.00 4 300.00 0.0000
2020-11-10 2020-09-30 13F MADRIGAL PHARMACEUTICALS COMMON STOCK 558868105 8 0 0.00 1 0.00 0.0000
2020-08-07 2020-06-30 13F MADRIGAL PHARMACEUTICALS COMMON STOCK 558868105 8 -228 -96.61 1 -93.75 0.0000
2020-05-13 2020-03-31 13F MADRIGAL PHARMACEUTICALS COMMON STOCK 558868105 236 8 3.51 16 -23.81 0.0000
2020-02-04 2019-12-31 13F MADRIGAL PHARMACEUTICALS COMMON STOCK 558868105 228 -31 -11.97 21 -4.55 0.0001
2019-11-08 2019-09-30 13F MADRIGAL PHARMACEUTICALS COMMON STOCK 558868105 259 228 735.48 22 633.33 0.0001
2019-08-13 2019-06-30 13F MADRIGAL PHARMACEUTICALS COMMON STOCK 558868105 31 0 0.00 3 -25.00 0.0000
2019-05-08 2019-03-31 13F MADRIGAL PHARMACEUTICALS COMMON STOCK 558868105 31 0 0.00 4 33.33 0.0000
2019-02-13 2018-12-31 13F MADRIGAL PHARMACEUTICALS COMMON STOCK 558868105 31 -67 -68.37 3 -85.71 0.0000
2018-10-31 2018-09-30 13F MADRIGAL PHARMACEUTICALS COMMON STOCK 558868105 98 47 92.16 21 50.00 0.0001
2018-08-08 2018-06-30 13F MADRIGAL PHARMACEUTICALS COMMON STOCK 558868105 51 51 14 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.